1. Home
  2. DYN vs CDLR Comparison

DYN vs CDLR Comparison

Compare DYN & CDLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • CDLR
  • Stock Information
  • Founded
  • DYN 1984
  • CDLR 2008
  • Country
  • DYN United States
  • CDLR Denmark
  • Employees
  • DYN N/A
  • CDLR N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • CDLR
  • Sector
  • DYN Health Care
  • CDLR
  • Exchange
  • DYN Nasdaq
  • CDLR Nasdaq
  • Market Cap
  • DYN 1.9B
  • CDLR 1.9B
  • IPO Year
  • DYN 2020
  • CDLR N/A
  • Fundamental
  • Price
  • DYN $14.22
  • CDLR $20.96
  • Analyst Decision
  • DYN Strong Buy
  • CDLR
  • Analyst Count
  • DYN 14
  • CDLR 0
  • Target Price
  • DYN $34.93
  • CDLR N/A
  • AVG Volume (30 Days)
  • DYN 2.4M
  • CDLR 49.4K
  • Earning Date
  • DYN 07-28-2025
  • CDLR 08-26-2025
  • Dividend Yield
  • DYN N/A
  • CDLR N/A
  • EPS Growth
  • DYN N/A
  • CDLR N/A
  • EPS
  • DYN N/A
  • CDLR 0.78
  • Revenue
  • DYN N/A
  • CDLR $546,159,718.00
  • Revenue This Year
  • DYN N/A
  • CDLR $116.02
  • Revenue Next Year
  • DYN N/A
  • CDLR $80.90
  • P/E Ratio
  • DYN N/A
  • CDLR $6.66
  • Revenue Growth
  • DYN N/A
  • CDLR 277.89
  • 52 Week Low
  • DYN $6.36
  • CDLR $17.37
  • 52 Week High
  • DYN $37.08
  • CDLR $28.75
  • Technical
  • Relative Strength Index (RSI)
  • DYN 73.48
  • CDLR 49.86
  • Support Level
  • DYN $13.03
  • CDLR $20.07
  • Resistance Level
  • DYN $13.85
  • CDLR $20.63
  • Average True Range (ATR)
  • DYN 0.64
  • CDLR 0.40
  • MACD
  • DYN 0.04
  • CDLR -0.08
  • Stochastic Oscillator
  • DYN 95.55
  • CDLR 35.60

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About CDLR Cadeler AS

Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning and provides marine and engineering operations to the wind industry, focusing on safety and the environment. The company operates six offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.

Share on Social Networks: